<?xml version="1.0" encoding="UTF-8"?>
<p>Tsai et al. observed quality of life in a RCT (
 <xref rid="B52" ref-type="bibr">Tsai et al., 2016</xref>). Thirty seven patients with advanced adenocarcinomas of breast, lungs, stomach, liver and colorectal region undergoing chemotherapy were enrolled and randomized to a 30-days-supplementary treatment with 
 <italic>Antrodia cinnamomea</italic> or placebo. Assessments of the EORTC-QLQ-C30 showed no significant differences between the groups other than sleep, which was significantly improved in the verum group (
 <italic>p</italic> = 0.04).
</p>
